Health safety issues of synthetic food colorants P Amchova, H Kotolova, J Ruda-Kucerova Regulatory toxicology and pharmacology 73 (3), 914-922, 2015 | 630 | 2015 |
Anticancer activity of artemisinin and its derivatives S Slezáková, J Ruda-Kucerova Anticancer research 37 (11), 5995-6003, 2017 | 178 | 2017 |
Principles of diffusion kurtosis imaging and its role in early diagnosis of neurodegenerative disorders A Arab, A Wojna-Pelczar, A Khairnar, N Szabó, J Ruda-Kucerova Brain research bulletin 139, 91-98, 2018 | 94 | 2018 |
Peripubertal cannabidiol treatment rescues behavioral and neurochemical abnormalities in the MAM model of schizophrenia T Stark, J Ruda-Kucerova, FA Iannotti, C D'Addario, R Di Marco, V Pekarik, ... Neuropharmacology 146, 212-221, 2019 | 77 | 2019 |
HDAC1 and HDAC3 underlie dynamic H3K9 acetylation during embryonic neurogenesis and in schizophrenia‐like animals J Večeřa, E Bártová, J Krejčí, S Legartová, D Komůrková, ... Journal of cellular physiology 233 (1), 530-548, 2018 | 76 | 2018 |
Sex differences in the reinstatement of methamphetamine seeking after forced abstinence in Sprague-Dawley rats J Ruda-Kucerova, P Amchova, Z Babinska, L Dusek, V Micale, A Sulcova Frontiers in psychiatry 6, 91, 2015 | 74 | 2015 |
Crosstalk between the transcriptional regulation of dopamine D2 and cannabinoid CB1 receptors in schizophrenia: Analyses in patients and in perinatal Δ9-tetrahydrocannabinol … M Di Bartolomeo, T Stark, OM Maurel, FA Iannotti, M Kuchar, ... Pharmacological Research 164, 105357, 2021 | 53 | 2021 |
Altered dopamine D3 receptor gene expression in MAM model of schizophrenia is reversed by peripubertal cannabidiol treatment T Stark, M Di Bartolomeo, R Di Marco, E Drazanova, CBM Platania, ... Biochemical Pharmacology 177, 114004, 2020 | 51 | 2020 |
Different effects of prenatal MAM vs. perinatal THC exposure on regional cerebral blood perfusion detected by Arterial Spin Labelling MRI in rats E Drazanova, J Ruda-Kucerova, L Kratka, T Stark, M Kuchar, M Maryska, ... Scientific Reports 9 (1), 6062, 2019 | 37 | 2019 |
Reactivity to addictive drugs in the methylazoxymethanol (MAM) model of schizophrenia in male and female rats J Ruda-Kucerova, Z Babinska, P Amchova, T Stark, F Drago, A Sulcova, ... The World Journal of Biological Psychiatry 18 (2), 129-142, 2017 | 37 | 2017 |
Early and progressive microstructural brain changes in mice overexpressing human α-Synuclein detected by diffusion kurtosis imaging A Khairnar, J Ruda-Kucerova, N Szabó, E Drazanova, A Arab, ... Brain, behavior, and immunity 61, 197-208, 2017 | 34 | 2017 |
Low vs. high alcohol: central benefits vs. detriments Y Tizabi, B Getachew, CL Ferguson, AB Csoka, KM Thompson, ... Neurotoxicity Research 34, 860-869, 2018 | 33 | 2018 |
Olanzapine-depot administration induces time-dependent changes in adipose tissue endocrine function in rats K Horska, J Ruda-Kucerova, Z Babinska, M Karpisek, R Demlova, ... Psychoneuroendocrinology 73, 177-185, 2016 | 32 | 2016 |
Reward related neurotransmitter changes in a model of depression: an in vivo microdialysis study J Ruda-Kucerova, P Amchova, T Havlickova, P Jerabek, Z Babinska, ... The World Journal of Biological Psychiatry 16 (7), 521-535, 2015 | 32 | 2015 |
Differential characteristics of ketamine self-administration in the olfactory bulbectomy model of depression in male rats. Z Babinska, J Ruda-Kucerova Experimental and clinical psychopharmacology 25 (2), 84, 2017 | 26 | 2017 |
Poly (I: C) model of schizophrenia in rats induces sex-dependent functional brain changes detected by MRI that are not reversed by aripiprazole treatment E Drazanova, J Ruda-Kucerova, L Kratka, K Horska, R Demlova, ... Brain research bulletin 137, 146-155, 2018 | 25 | 2018 |
Both ketamine and NBQX attenuate alcohol drinking in male Wistar rats J Ruda-Kucerova, Z Babinska, M Luptak, B Getachew, Y Tizabi Neuroscience letters 666, 175-180, 2018 | 25 | 2018 |
Suppression of methamphetamine self-administration by ketamine pre-treatment is absent in the methylazoxymethanol (MAM) rat model of schizophrenia J Ruda-Kucerova, Z Babinska, T Stark, V Micale Neurotoxicity research 32, 121-133, 2017 | 20 | 2017 |
Late‐stage α‐synuclein accumulation in TNWT‐61 mouse model of Parkinson's disease detected by diffusion kurtosis imaging A Khairnar, J Ruda‐Kucerova, E Drazanova, N Szabó, P Latta, A Arab, ... Journal of neurochemistry 136 (6), 1259-1269, 2016 | 19 | 2016 |
Diffusion kurtosis imaging detects microstructural alterations in brain of α-synuclein overexpressing transgenic mouse model of Parkinson’s disease: a pilot study A Khairnar, P Latta, E Drazanova, J Ruda-Kucerova, N Szabó, A Arab, ... Neurotoxicity research 28, 281-289, 2015 | 19 | 2015 |